Out-of Pocket Payments With Lymphedema in France (Lymphorac)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02988505|
Recruitment Status : Completed
First Posted : December 9, 2016
Last Update Posted : February 27, 2019
Lymphedema is a frequent and chronic condition posing a high burden on patients. Clinical guidelines emphasize the role of compression therapy by prescription medical devices. Even in a mandatory publicly funded health insurance system, out-of-pocket payments (OOPP) may exist due to the price and reimbursement setting processes. OOPP may threaten the equity of care and drive patients to forgo care. Our aim was to analyze the distributive effects of OOPP for lymphedema patients in France.
A prospective, multicenter study will be conducted in France in 2014 on patients with lymphedema. Household ability to pay will be specified by net income and OOPP will be assessed prospectively over 6 months for outpatient care (visits, drugs, medical devices, nursing care, biological tests, imaging, physiotherapy and transportations). Both mandatory and voluntary health insurance reimbursements will be considered. We will combine concentration curves and concentration indices to assess the distributive effects.
|Condition or disease||Intervention/treatment|
|Primary Lymphedema Secondary Lymphedema||Other: Standard care|
|Study Type :||Observational|
|Actual Enrollment :||260 participants|
|Official Title:||Out-of Pocket Payments in Patients With Lymphedema in France and Inequities of Access ti Healthcare|
|Actual Study Start Date :||September 3, 2014|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2017|
- Other: Standard care
Other Name: Standard care including medical visits , drugs and medical devices
- The mean monthly out-of-pocket payment as assessed by an online self-questionnaire [ Time Frame: 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02988505
|Departement information Medicale CHU Montpellier|
|Montpellier, France, 34000|